Widespread Generic Erosion of Atypical Antipsychotics Will Cause the Bipolar Disorder Drug Market to Decline By More Than $1 Billion Through 2018
»

Posted By knowledgefield 1 month, 2 weeks ago in Business & Finance

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that widespread generic erosion of branded atypical antipsychotics will cause the bipolar disorder drug market to decline from $6.3 billion in 2008 to approximately $5 billion in 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.

Read Full Story at reuters.com »

3 Views Share Story 0 Comments Report

Submitted By:
knowledgefield

Other Related Articles: All »

RSS Join the Discussion

+ Add Comment
Comments So Far: 0 (view all)
- Display

Add a Comment

Sign In With Your Propeller Account

Forgot your password?

Please keep your comments relevant to this story.

To create a live link, simply type the URL (including http://) or email address and we will make it a live link for you. You can put up to 3 URLs in your comments. Line breaks and paragraphs are automatically converted — no need to use <p> or <br /> tags.

Submit a Story

Advertisement

Story Tags ?

patent expiry disorder bipolar antipsychotics market

Hey! If you Sign In, you can add tags to this story!

Real Estate Info

Get the Latest Market Info for Your Area



Foreclosures | Short Sale

Luxury Homes | Homes for Sale

First Time Home Buyer Advice



Propping This Article

view all »

Dropping This Article

No one has dropped this story.

Groups Watching This

No groups are watching this story. Why not share it with your groups?

Also Submitted By

No one else has submitted this story.